Return to Listing

1 result(s) for

PI Name Protocol # Title
Jacqueline Vuky STUDY00018878 A phase 1 study of FOR46 administered every 21 days in patients with metastatic castration-resistant prostate cancer (mCRPC)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080